H.M.H. Zakaly

[ 1 ] - Biokinetic modelling of 89-Zr-labelled monoclonal antibodies for dosimetry assessment in humans

Background: Monoclonal antibodies have confirmed their merit as biotherapeutics across a wide spectrum of diseases, including cancer, heart disease, infection, and immune disorders. Materials and Methods: The dynamics of 89Zr-labelled monoclonal antibodies (MAb) after injection into the human body are modelled. This modified biokinetic model can be used for dose assessment not only for 89Zr-lab...